BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18077133)

  • 1. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
    Lukong KE; Richard S
    Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
    Lukong KE; Larocque D; Tyner AL; Richard S
    J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
    Weaver AM; Silva CM
    Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
    Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
    J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
    Lukong KE; Huot ME; Richard S
    Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
    Tsui T; Miller WT
    Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
    Kim HIe; Lee ST
    J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brk/PTK6 signaling in normal and cancer cell models.
    Ostrander JH; Daniel AR; Lange CA
    Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Brk kinase and insulin receptor substrate-4.
    Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
    Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
    Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
    PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
    Ai M; Liang K; Lu Y; Qiu S; Fan Z
    Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.
    Mitchell PJ; Sara EA; Crompton MR
    Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
    Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
    Qiu H; Miller WT
    J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
    Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of STAT3 as a specific substrate of breast tumor kinase.
    Liu L; Gao Y; Qiu H; Miller WT; Poli V; Reich NC
    Oncogene; 2006 Aug; 25(35):4904-12. PubMed ID: 16568091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.